Clinexpert Kft.

At Clinexpert Kft., investigators are exploring innovative approaches to manage atherosclerotic cardiovascular disease and its complications, emphasizing long‑term safety and patient‑centered outcomes.

• Evaluation of novel anti‑inflammatory agents for cardiovascular risk reduction
• Assessment of renal‑cardiac interaction in chronic kidney disease
• Biomarker‑driven strategies to personalize therapy

These studies aim to lower event rates and improve quality of life for individuals at risk of heart disease.

Research at the site focuses on improving treatment for inflammatory bowel disease and primary biliary cholangitis, seeking therapies that alleviate fatigue and cognitive symptoms while ensuring tolerability.

• Testing new agents for ulcerative colitis with moderate to severe activity
• Investigating therapies that target fatigue in primary biliary cholangitis
• Exploring gut‑focused immunomodulation in gastrointestinal cancers

The goal is to provide better symptom control and disease management for patients with chronic digestive disorders.

The oncology program evaluates cutting‑edge treatments for cancers such as non‑small cell lung cancer, tumors with KRAS G12C mutation, and high‑risk early‑stage breast cancer, aiming to enhance survival and personalize care.

• Combination immunotherapy for advanced lung cancer
• Targeted agents for KRAS‑mutated solid tumors
• Adjuvant therapies to prevent recurrence in early‑stage breast cancer
• Therapeutic cancer vaccine evaluation after immunotherapy failure

These trials strive to extend patient survival and expand therapeutic options across multiple tumor types.

Studies address neuropsychiatric challenges by testing novel compounds for agitation in Alzheimer’s disease, with a focus on safety, tolerability, and improvement of daily functioning.

• Evaluating new agents to reduce agitation in dementia patients
• Safety profiling of neuro‑psychiatric medications
• Improving cognitive outcomes and caregiver support

The aim is to enhance quality of life for individuals living with neurodegenerative conditions and their families.

The site investigates fundamental digestive system physiological processes and their link to oral health, seeking biomarkers and diagnostic tools for early disease detection.

• Studying biomarkers of gastrointestinal function
• Assessing the impact of the oral microbiome on systemic disease
• Developing diagnostic assays for early detection of digestive disorders

Findings may lead to earlier interventions and targeted therapies for both oral and gastrointestinal health.